tm
Seeing Is Believing
tm
Seeing Is Believing
IKT is currently covered by 2 analysts with an average price target of $42.1. This is a potential upside of $40.7 (2907.14%) from yesterday's end of day stock price of $1.4.
Inhibikase Therapeutics 's activity chart (see below) currently has 1 price targets and 5 ratings on display. The stock rating distribution of IKT is 25% HOLD and 75% BUY.
Highest price target for IKT is $27, Lowest price target is $27, average price target is $42.1.
Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 07-Mar-2024. First documented stock forecast 15-Jul-2021.
Currently out of the existing stock ratings of IKT, 1 are a HOLD (25%), 3 are a BUY (75%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
27
$25.6 (1828.57%)
2 months 2 days ago
0/2 (0%)
$24.58 (1015.70%)
Hold
72
1 years 5 months 23 days ago
0/1 (0%)
$56.82 (374.31%)
What is IKT (Inhibikase Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on IKT (Inhibikase Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on IKT (Inhibikase Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on IKT (Inhibikase Therapeutics )?
Which analyst is the currently most bullish on IKT (Inhibikase Therapeutics )?
Which analyst is the currently most reserved on IKT (Inhibikase Therapeutics )?
